- $10.39bn
- $10.79bn
- $7.82bn
- 80
- 49
- 80
- 79
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,950 | 6,531 | 6,404 | 6,700 | 7,824 |
Cost of Revenue | |||||
Gross Profit | 1,058 | 695 | 824 | 896 | 1,274 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 9,308 | 10,037 | 6,432 | 6,533 | 7,315 |
Operating Profit | -2,358 | -3,507 | -28 | 168 | 509 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2,571 | -3,499 | 198 | 68.9 | 207 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2,650 | -3,518 | 87 | -36.5 | 51.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -2,415 | -3,288 | 13.3 | -107 | 56.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2,415 | -3,288 | 13.3 | -107 | 56.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.32 | -2.99 | 0.317 | -0.073 | 0.153 |
Dividends per Share |